Angiotech Pharmaceuticals, Inc

Angiotech Pharmaceuticals, Inc. is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug, paclitaxel. These treatments are based upon our discovery that paclitaxel, one of the most commercially successful and clinically effective anticancer drugs ever produced, also blocks an important cellular pathway involved in inflammation.
Angiotech's goal is to establish a leadership position in the development of treatments for chronic inflammatory diseases.

Activity:

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

- Arthritis / Rheumato
- Cancer
- Dermatology
- Infectious Diseases

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees: 56

Turnover:

Amount:	Year:	Currency:

Year founded:

Stock options:

	Symbol	Exchange
1	ANP	TSX (Toronto)
	Symbol	Exchange
2	ANPI	Nasdaq